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ABSTRACT
The bacterium Streptococcus pyogenes requires heme, which is taken up via an ABC transporter.
An understanding of this pathway may result in new approaches to antibacterial agents. Both
SiaA and NEAT2 (NEAr Transporter 2) are proteins involved in heme binding. One of the axial
ligands of SiaA, His 229, was purified to study how mutagenesis affects heme binding. UVvisible studies showed a small band at 420 nm with respect to the protein band at 288 nm which
probably indicates that heme was lost easily from this mutant. We have also worked to optimize
the yield of Shr-NEAT2 by changing different variables. For each of the batches, the yield of
holoNEAT2 was calculated by UV-visible spectroscopy. Increasing oxygen during growth did
not improve holoNEAT2 yield. On the other hand, lower temperature, decrease in time after
induction, and addition of ALA all increased the protein production.
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CHAPTER 1. SIAA, A HEME BINDING PROTEIN
1.1. Overview of S. pyogenes, a pathogenic bacterium.
S. pyogenes, also known as Group A streptococcus (GAS) and the “flesh eating
bacterium,” is a gram positive pathogen which targets the throat and skin. Common diseases of
this bacterium are pharyngitis, impetigo, scarlet fever, toxic shock syndrome, and post
streptococcal infections which include rheumatic fever (Cunningham, 2000).
Antibiotic resistance of common pathogens is a growing clinical issue (Kumar &
Schweizer, 2005; Poole, 2007; Li & Nikaido, 2009; Martinez et al., 2009) making the
development of new antibiotics a high priority. One strategy for the development of novel
antibiotics is to target a pathway found in bacteria, but not in humans. Because humans make
their own heme (Dailey, 1997; Heinemann et al., 2008). The heme uptake pathway is an
excellent target for those bacteria which do not have the genetic machinery to produce their own
heme. S. pyogenes is such a bacterium, and therefore its heme uptake pathway is an excellent
pharmaceutical design target (Skaar & Schneewind, 2004).
Many pathogenic bacteria can use heme to acquire iron needed for their survival
(Wandersman & Delepelaire, 2004; Crosa et al., 2004; Wilks & Burkhard, 2007; Cavallaro et al.,
2008; Krewulak & Vogel, 2008; Tong & Guo, 2009). Heme accounts for approximately 75% of
iron in humans (Grigg et al., 2007b). Pathogens have developed mechanisms to acquire iron
from heme (Wilks & Burkhard, 2007; Cavallaro et al., 2008). The systems in which heme is used
have been related to virulence and infections (Wilks & Burkhard, 2007; Grigg et al., 2007b).
Cavallero et al. have analyzed 437 genomes known to be related to heme biosynthesis
and uptake in bacteria (Cavallaro et al., 2008). Of these, 138 can synthesize heme, 20 can obtain
heme from an external source, 218 can do both and 61 can do neither. Thus, 86% of bacteria
1

analyzed can synthesize heme, acquire heme, or both. S. pyogenes can acquire heme from its
environment, taking it from hemoglobin, myoglobin, heme-albumin, catalase and the
hemoglobin/haptoglobin complex (Francis, Jr. et al., 1985; Eichenbaum et al., 1996).
1.2 ABC Transporters.
Bacteria use different transport systems to acquire iron (in the case of S. pyogenes, an
ATP-Binding Cassette (ABC) transporter is used shown in Figure 1). ABC transporters are
membrane proteins that use ATP hydrolysis to transport molecules across membranes (Jones &
George, 2004; Davidson & Maloney, 2007; Hollenstein et al., 2007). They are classified as
primary active transporters meaning that movement of molecules occurs against a gradient,
requiring energy. These transporters are found in prokaryotes and eukaryotes and take part in
processes such as homeostasis, bacterial immunity, and uptake of molecules by pathogenic
bacteria.
ABC transporters move molecules in one direction through the membrane. They are
classified as importers and exporters. Importers are found in prokaryotes, and need a binding
protein to deliver molecules to the transporter. Exporters are found in prokaryotes and eukaryotes
and do not need a binding protein; they obtain the molecules to be transported directly from the
cytoplasm.
ABC transporters are made of two transmembrane domains (TMD) and two nucleotidebinding domains (NBDs). The TMDs vary in length, primary sequence, and number of
transmembrane helices. TMDs are formed of hydrophobic segments which form channels needed
for the transport of molecules.
NBDs have a conserved three-dimensional structure. NBDs are hydrophilic molecules
and undergo conformational changes promoted by the hydrolysis of ATP. NBDs are divided into
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subparts including the Walker A and B motifs, LSGGQ motif, Q-loop, D-loop, and A-loop. The
C- loop allows interaction of the ATP γ-phosphate from the other subunit of the dimer. The Dloop is involved in the interactions of the two NBDs. The Q-loop is involved in the NBD-TMD
contact. The A-loop is part of the catalytic reaction.
The conformational changes in NBDs are transferred to the TMDs through non-covalent
interactions. There are several motifs involved with NBDs which provide for the binding of
ATP, place correct amino acids in appropriate position for hydrolysis, and contact with TMDs
and NBDs.
The HI1470/1 transporter from Haemophilus influenzae and the BtuCD (cobalamin)
transporter from E. coli have side by side interaction of TMDs (Davidson & Maloney, 2007).
However, the translocation pathways are different. In the HI1470/1 transporter, the translocation
pathway is open to the cytoplasm and access from the periplasmic side is restricted by residues in
the TM helices. In BtuCD, the translocation pathway is open to the periplasm and access to the
cytoplasm is restricted by residues in the TM helices.
The ABC transporter that takes up heme in S. pyogenes is termed SiaA (Bates et al.,
2003) and alternatively HtsA (heme transport) (Liu & Lei, 2005). SiaA (spy 1795) is part of a 10
gene cluster (Figure 1); SiaB (spy 1794) and SiaC (spy 1793) are immediately downstream.
Upstream are two additional proteins in the cluster, Shr and Shp. It is now known that heme is
transferred from Shr to Shp to SiaA (Lei et al., 2002; Lei et al., 2003; Liu & Lei, 2005; Nygaard
et al., 2006) In this chapter, we outline information related to SiaA and Shp; background
information relevant to Shr is given in Chapter 2.
Shp is a heme binding protein found in S. pyogenes cell surface (Zhu et al., 2008b). UVvisible spectroscopy studies show that heme is transferred from hemoglobin to apo-Shp, forming

3

holo-Shp. Holo-Shp has a six-coordinate heme center and shows abosrption peaks at 428, 528,
and 560 nm (Nygaard et al., 2006). UV-visible spectroscopy studies show that Shp transfers
heme to SiaA but that SiaA does not transfer heme back to Shp. The crystal structure of Shp
shows that heme binds with two methionine residues, Met153 and Met66 (Aranda et al., 2007).
SiaA is a 37 kDa heme binding lipoprotein. MCD (magnetic circular dichroism), NMR
(nuclear magnetic resonance), and rR (resonance Raman) studies demonstrated that this protein
has a six coordinate heme center (Sook et al., 2008). Holo-SiaA has an absorption peak at 412
nm (Liu & Lei, 2005). Protein denaturation with guanidinium showed that the ferric state of the
protein is less stable than the ferrous state (Sook et al., 2008). SiaA has two axial ligands, His229
and Met79 (Figure 2). The mutation of these two residues to alanines showed a decrease in the
intensity of the Soret band.
1.3 SiaA homologs.
SiaA homologs are found in both Gram positive and Gram negative bacteria. Because the
first chapter of this thesis focuses on SiaA, we describe here literature studies on known
homologs including IsdE (SiaA threaded into IsdE shown in Figure 3) from the Gram positive
bacteria Staphylococcus aureus as well as ShuT, PhuT, ChuX and HmuY from Gram negative
bacteria.
1.3.1 IsdE.
IsdE is a 33 kDa heme binding lipoprotein found in Staphylococcus aureus (Grigg et al.,
2007a). This protein contains a long α- helix. IsdE contains two domains that have beta-sheets
surrounded by α-helices. In the C-terminal domain there are 5-stranded β-sheet and in the Nterminal domain there are a total of two β-strands.
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IsdE contains a 6-coordinate heme center. IsdE showed a strong Soret band at 400 nm
(Grigg et al., 2007a). In early work, the mutation of each His229 and Met78 to alanine
individually showed reduction of heme binding in UV-visible spectra. The mutation of His229
and Met78 together showed higher reduction of heme binding than each mutant individually.
This data suggested that both His229 and Met78 were probable axial ligands. The H229A
spectrum was found to be different from the WT IsdE in the MCD spectrum. WT IsdE showed a
band at 568 nm in the MCD spectrum but H229A showed a band at 590 nm (Pluym et al., 2007).
The crystal structure of IsdE shows that besides participating as an axial ligand, His229 is
involved in hydrogen bonding in the heme binding pocket. One of the hydrogen bonds that it
forms is with Glu265 (Grigg et al., 2007a).
1.3.2 PhuT.
PhuT is a 33 kDa heme binding protein found in Pseudomonas aeruginosa (Tong & Guo,
2007). PhuT contains a five-coordinate ferric heme center. The protein is comprised of 24-26%
α- helices, 20-21% of β-sheets, 19-22% of turns and 28-37% of other structures (Tong & Guo,
2007).
PhuT showed a broad Soret band at 400 nm. Besides this band, PhuT showed bands at
500, 534, and 624 nm. Addition of a reducing agent, dithionite, produced a redshift of the 400,
500 and 534 nm bands to 420, 560 and 589 nm, respectively.
A recent X-ray study has shown that Tyr71 is the axial ligand of PhuT (Tong & Guo,
2007). The WT PhuT as well as the Y71F and Y146F mutants were studied. Y146 was not
proposed as a possible axial ligand, but it was mutated to F in order to compare the results with
Y71F. The Y146F PhuT mutant showed a UV-visible spectrum similar to WT PhuT. However,
Y71 showed a different spectrum, consistent with the role of this residue as the axial ligand.
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1.3.3 ShuT.
ShuT is a 28.3 kDa heme binding protein found in Shigella dysenteriae (Eakanunkul et
al., 2005). ShuT contains a five-coordinate ferric heme center. Wild type ShuT showed a Soret
band at 400 nm. Other bands were detected at 500, 521, and 617 nm. In early work, Y94A,
Y228F, and Y228F /Y94A spectra were compared to determine the probable axial ligand of
ShuT (Eakanunkul et al., 2005). The spectrum of the Y228/Y94A and Y94A mutants were
similar to one another and different from WT ShuT. The spectra similarity between WT ShuT
and Y288F indicated that Y228 was probably not an axial ligand (Eakanunkul et al., 2005).
Thus, it was concluded that Y94 was the probable axial ligand.
The crystal structure of ShuT indicated that Tyr94 is the heme axial ligand. This was also
indicated by resonance Raman spectroscopy and magnetic circular dichroism spectroscopy. In
the resonance Raman spectrum, WT ShuT and Y228F ShuT mutant showed similar or identical
bands. Likewise, Y94A and Y228F/Y94A showed similar or identical bands in the spectrum. For
example, the v10 band for WT ShuT and Y228F ShuT mutant was at around 1616 cm-1. For
Y94A and Y228F/Y94A, the v10 band was at 1625 cm-1. The MCD spectra results corresponded
with the resonance Raman results. The spectra for WT ShuT and Y228F ShuT mutant were
found to be almost the same. The spectra of Y94A and Y288F/Y94A were also found to be very
similar to each other. Both resonance Raman spectroscopy and MCD indicated that Tyr94 was
the axial ligand of ShuT. MCD did not show the presence of a histidine ligand.
1.3.4 ChuX. ChuX is a heme binding protein found in E. coli (Suits et al., 2009). This protein is
a homodimer, each half of which binds two hemes. Spectral studies show that the ferric ChuX
has a combination of 5-coordinate high spin and 6-coordinate low and high spins. Ferrous ChuX
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has a combination of 5-coordinate high spin and 6-coordinate low spin states. This protein has
two axial ligands, His65 and His98.
1.3.5 HmuY. HmuY is a heme binding lipoprotein from the bacterium Porphyromonas
gingivalis (Olczak, 2006; Olczak et al., 2008). HmuY is found as a monomer but can also form
dimers and oligomers. This protein binds heme as shown by UV-visible spectroscopy studies
mixing hemin with apo-HmuY. HmuY has two axial ligands, His134 and His166 (Wojtowicz et
al., 2009c; Wojtowicz et al., 2009a; Wojtowicz et al., 2009b). The crystal structure of this protein
shows a tetrameric quaternary structure and iron has an octahedral coordination.
1.4 Experimental
LB medium preparation. A batch of LB medium was made by adding 15 g tryptone, 7.5 g
BactoTM yeast extract, 15 g NaCl, and 1500 mL water to a 2.8 L Erlenmeyer flask. The pH was
adjusted to 7.01 by addition of aqueous NaOH. The solution was autoclaved using the liquid
cycle for 15 min and cooled to room temperature. A total of 1.5 mL AMP stock solution was
added to the LB medium. LB medium (30 mL) was added to a 125 mL Erlenmeyer flask.
Inoculation of LB medium and growth of H229A transfected E. coli. Under sterile
conditions, Top10ShuA-His [a gift from Dr. Eichenbaum (Georgia State University)] was added
with an inoculating loop to the 50 mL solution in the 125 mL Erlenmeyer flask. The solution was
shaken for a period of 16 h at 37°C, at which point OD660 was about 1. The remaining LB
solution (~1450 mL at room temperature) was mixed with new inoculated solution and shaken
for 3 h at 37°C to a final OD660 of 0.5. A 2% arabinose stock solution [a gift from Kyle Chan
(Georgia State University)] was prepared by dissolving 4 g L-arabinose (Acros Organics, New
Jersey) in 200 mL sterile water. A total of 7.5 mL of 2% arabinose stock solution was added to
the flask. The flask was incubated for 4 h at 37°C. The culture broth was evenly distributed into
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1 L sterile plastic centrifuge bottles and centrifuged at 8000 x g for 20 min at 4°C. The
supernatant was discarded; the pellet was scraped into a sterile vial and the sample stored in the 80°C freezer.
French press sample preparation and pressing. The centrifuge bottles containing the cell
pellet were removed from the -80 °C freezer and quickly thawed using warm water. The cell
pellets were transferred from the centrifuge bottles to a 50 mL Falcon tube using an inoculating
loop. Approximately, 40 mL of lysis buffer (1 L lysis buffer: 20 mL of 1 M Tris HCl, pH 8.0
from 20 mM Tris base, 100 mM NaCl, 1 mL of 0.1% Triton X-100 (Fisher Scientific), and 100
mL 10% glycerol ) [(a gift from Joy Zhou (Georgia State University)] was added to a 50 mL
Falcon tube. A total of 4 protease inhibitor tablets (Complete Mini, EDTA-free, Roche
Diagnostics, Mannheim, Germany) was added and dissolved. The solution then was divided into
two Falcon tubes, each with approximately the same amount of solution. The solutions were
placed on ice and kept on ice while not being actively French pressed. A SimAminco French
pressure cell press was used on high setting and adjusted to a display psi of 1280. Ethanol was
sprayed in the plunger to make insertion easier. A large Thermo French press cell (35 mL
maximum volume), kept at 4 ºC, was loaded with one sample (~20 mL). The sample was
released by slowly tapping on the T-screw and putting it in its original Falcon tube in the ice
bucket. After the sample was collected, the selector was set to down and the sample remaining
was stored also in the Falcon tube. Each solution was French pressed twice. The pressure was
decreased to 0 psi and the French press machine was turned off. The French press equipment was
cleaned with water and ethanol and air dried before it was stored in the refrigerator. The samples
in the Falcon tubes were centrifuged at 15,000 × g for 20 min at 4 ºC. The supernatant was
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decanted and the solution was filtered using syringe and a Nalgene disposable bottle top filter
150 mL 0.45 μm pore size (Fisher Scientific).
SDS-PAGE gel preparation (sodium dodecyl sulfate polyacrylamide gel electrophoresis)
Resolving and stacking gel solutions were made to prepare two 0.75 mm SDS-PAGE gels. The
resolving gel solution was made by adding 2.3 mL water, 5.0 mL 30% acrylamide (made by
adding 30 g of acrylamide/bis (EM Science, Gibbstown, NJ) and 100 mL water), 2.5 mL 1.5 M
Tris pH 8.8 (made by dissolving 36.34 g Tris (FisherBiotech, Fair Lawn, NJ) in water to make a
200 mL stock solution), 100 μL 10% SDS (sodium dodecyl sulfate) (made by mixing 1 g SDS
with 10 mL water), 100 μL 10% APS (ammonium persulfate) (made by mixing 1 g AMP sodium
salt (FisherBiotech) with 10 mL of sterile water), and 4 μL TEMED
(tetramethylethylenediamine) (Bio-Rad Lab) into an autoclaved Erlenmeyer flask. The stacking
gel solution was made by adding 6.8 mL water, 1.7 mL 30% acrylamide, 1.25 mL 1.0 M Tris pH
6.8 (made by dissolving ~25 g Tris in water to make a 200 mL stock solution), 10% SDS, 100
μL 10% APS, and 10 μL TEMED into an autoclaved Erlenmeyer flask. The resolving gel was
poured first, 2-propanol was added, and the gel was dried for ~ 40 min. Water was used to rinse
the gel; filter paper was used to remove excess water, and the stacking gel was added and dried
for ~ 40 min.
SDS-PAGE gel run. A running buffer solution was made by adding 50 mL Tris-glycine-SDS
10X (Fisher Scientific) and 450 mL water in a volumetric flask and was inverted five times. The
Mini-PROTEAN 3 cell equipment was set up as outlined in the manual using 0.75 mm plates.
The running buffer was added to the Mini-PROTEAN 3 cell equipment. A sample buffer was
made by adding 25 μL of 2-mercaptoethanol (Bio-Rad Lab) and 475 μL of Laemmli sample
buffer (Bio-Rad Lab) into an Eppendorf tube. The Laemmli sample buffer provided the dye for
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the protein. A total of 20 μL of sample buffer and 10 μL of the protein (NEAT2) were mixed in
an Eppendorf tube, centrifuged in the VWR Mini Centrifuge C-1200 at 6,000 × g for 30 s, and
heated for 5 min in the heat block at 103 ºC. The Precision Plus All Blue Standards protein
ladder (5 μL) (Bio-Rad Lab) and the sample buffer plus protein (10 μL) were loaded into
different wells. The electrophoresis system was initially set to 70 V. When the dye front was
approximately 1 cm below the bottom of the well, the system was switched to 118 V. The
sample was run until the dye front reached the bottom of the SDS-PAGE gel. Destaining solution
was prepared by adding 500 mL of methanol (Caledon, Georgetown, Canada) to 400 mL of
water and 100 mL glacial acetic acid (EMD, Gibbstown, NJ). Staining solution was prepared by
adding 0.5 g Coomassie Brilliant Blue R-250 (Bio-Rad Lab) to 200 mL of destaining solution.
The gel was washed with water and placed in staining solution for 30 min. The gel was placed in
destaining solution for 1 h and 30 min. The gel was dried using the DryEase Mini-Gel Drying
System (Invitrogen, Carlsbad, CA).
Nickel affinity FPLC followed the published protocol (Sook et al., 2008).
UV- visible spectroscopy. A Cary 50 Bio UV-visible spectrophotometer was used for all the
absorbance determinations. To each 100 µL of protein, 300 µL of 20 mM Tris-Cl 10% glycerol
buffer (recipe) were added in a 6Q cuvette. The base line was recorded with the blank sample
that contained the buffer 20 mM Tris-Cl 10% glycerol. The range used to record the spectrum
was 700 – 250 nm.
Western blotting. The equipment for Western blotting (Bio-Rad) was prepared by soaking two
fiber pads in transfer buffer [a gift from Tanu Soni (Georgia State University)]. A PVDF
(polyvinylidene fluoride) membrane with filter paper (a gift from Tanu Soni) was used for the
blotting and was soaked in transfer buffer. The gel sandwich cassette was set up with the black
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side down on a clean surface. A pre-wetted fiber pad was placed on the black side of the cassette,
followed by a piece of filter paper, the SDS-PAGE gel, the pre-wetted membrane, a piece of
filter paper on top of the membrane, and the last fiber pad. A glass tube was used to remove any
air bubbles found on the membrane. The cassette was placed in the module and the frozen BioIce cooling unit was placed on one of the sides of the cassette. The apparatus was set to 70 V and
was run for 1 h. A TBST (Tris-Buffered Saline Tween) (20 mL Tris HCl adjusted to pH 7.5, 30
mL of 5 M NaCl, and 950 mL water for a total of 3 L and Tween (Invitrogen, Carlsbad, CA)
added to a 0.05% concentration solution) (a gift from Tanu Soni) was added to the protein side of
the membrane and rotated for 5 min twice. A blocking solution was prepared by mixing 1.5 g of
skim milk and 25 ml of TBST. The blocking solution was placed on the membrane for one hour
after the TBST was discarded. The anti-SiaA antibody (a gift from Dr. Eichenbaum) solution
was prepared by adding 1 μL of anti-SiaA antibody to the blocking solution. The anti-SiaA
antibody was placed on the membrane and rotated for 1 h. The anti-SiaA antibody solution was
poured out and the membrane washed with TBST for 5 min three times. A total of 2.5 μL of antirabbit antibody solution (a gift from Dr. Eichenbaum) was added to 25 mL of blocking solution
and poured in the membrane for one hour. The membrane was washed with TBST three times
and once with TBS. The substrate was prepared by adding one ready to use tablet of BCIP +
NBT (Roche Applied Science, Indianapolis, IN) with 10 mL of Tris HCl and MgCl2. The
substrate was added to the membrane and placed in a dark place for approximately 8 min until
color developed. Water was used to stop the color development.
Homology modeling using LOOPP (Learning, Observing and Outputting Protein Patterns)
(Teodorescu et al., 2004) and Rasmol (Sayle & Milner-White, 1995) The wild type SiaA
protein sequence was threaded using LOOPP, (http://cbsuapps.tc.cornell.edu/loopp.aspx). First,
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the sequence was pasted in the “input sequence” section. A total of 5 homologous sequences
were obtained and three were chosen based on percent similarity: BtuF (1N2Z_A), CeuE
(2CHU_A), and FhuD (1K7S_N). The chosen structures were visualized using Rasmol.
BLAST (Basic Local Alignment Search Tool). The PhuT, ShuT, and IsdE protein sequences
were analyzed using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi)(Altschul et al., 1997). First,
the FASTA sequence was pasted into the protein-blast program. The algorithm selected was
blastp (protein-protein BLAST). Several homolog sequences were obtained but only the most
similar were analyzed.
1.5 Results and Discussion
1.5.1 Homology Modeling and BLAST
The text above summarizes the X-ray structures of PhuT, ShuT, and IsdE. In early work (before
the X-ray structures were known), we performed homology modeling of these proteins. This
section will outline those studies. Also, in early work we performed homology modeling of SiaA
with proteins that had known crystal structures. The work is not described in the text but can be
seen in Figure 4.
1.5.1.1 PhuT.
PhuT was analyzed with BLAST and several homolog sequences were obtained. The
sequences that were examined for identities, positives (similarities), and gaps were those of
CeuE in a complex with the iron binding mecam, BtuF: the vitamin B12 binding protein of E.
coli, and FhuD complexed with gallichrome. The identities, positives, and gaps percentages were
found to be very similar for CeuE (23%, 44%, and 6%, respectively), BtuF (25%, 44%, and 5%,
respectively) and FhuD showed (23%, 37%, and 6%, respectively).
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PhuT was threaded into three homologs: CeuE (2CHU_A); BtuF (1N4A_A); and FhuD
(1EFD_N). The amino acids around the heme binding pocket were examined and compared with
the heme binding pocket of PhuT.
The heme binding pocket of PhuT showed one axial ligand, Tyr71. The structures of
CeuE, BtuF, and FhuD showed Tyr71 in the heme binding pocket. The three homologs showed
Try71 in a similar position as Tyr71 in PhuT.
The heme binding pocket of PhuT also showed the charged residues, Arg73 and Arg228.
These positively charged amino acids can interact with the two heme-propionates. PhuT showed
other charged amino acids such as His and Lys but there are not located on the heme binding
pocket. CeuE and BtuF illustrated Arg73 and Arg228 on the heme binding pocket. The side
chains of Arg73 and Arg228 in CeuE and BtuF point to the center of the pocket. FhuD has three
Arg in the pocket the pocket, Arg73, Arg236, and Arg228. The Arg residues point to its center.
Arg was the only charged amino acid that seems to interact in the pocket. The other charged
amino acids such as His and Lys are not close to the pocket or are not well positioned to bind
with other molecules.
1.5.1.2 ShuT.
ShuT was analyzed with a BLAST search and several homolog sequences were obtained.
The identities, positives, and gap percentages were found to be very similar for CeuE (23%,
44%, and 7%, respectively) and BtuF (28%, 51%, and 4%, respectively).
ShuT was threaded into three homologs CeuE (2CHU_A); BtuF (1N4A_A); and FhuD
(1EFD_N). The amino acids around the heme binding pocket were examined.

13

The heme binding pocket of ShuT showed one axial ligand, Tyr 94. The structures of
CeuE, BtuF, and FhuD showed Tyr94 on the heme binding pocket. The three homologs showed
Tyr94 in a similar position as ShuT.
The heme binding pocket also showed charged residues. CeuE showed Lys122 and
Arg164 on the heme binding pocket. Lys122 and Arg164 were not located close to each other.
FhuD showed Lys122 and Arg164 on the pocket. The side chains of Lys122 and Arg164 pointed
towards the middle of the pocket. Lys122 and Arg164 were located on the same side of the heme
binding pocket. BtuF showed Lys116 and Arg185 on the pocket. The side chains of Lys116 and
Arg185 pointed towards the heme binding pocket. BtuF showed two His close to the heme
binding pocket but the immidizole rings point away from the pocket. Lys and Arg were the only
positively charged amino acids that seemed to interact in the heme binding pocket.
1.5.1.3 IsdE. IsdE was threaded into four homologs CeuE (2CHU_A); BtuF (1N4A_A); FhuD
(1EFD_N); and FeuA from Bacillus subtilis (2PHZ_A). The amino acids around the heme
binding pocket were examined.
The heme binding pocket of IsdE showed two axial ligands, His229 and Met78. The
structures of CeuE, BtuF, FhuD, and FeuA showed both His229 and Met78 in the heme binding
pocket. For all the structures, His229 and Met78 were located in opposite sides of the pocket.
The only difference was that the structure of BtuF showed both axial ligand farther apart than
His229 and Met78 in CeuE, FhuD, and FeuA.
The heme binding pocket also showed charged residues. IsdE showed Lys62 and Arg206
in the heme binding pocket. The side chains of Lys62 and Arg206 pointed towards the center of
the heme binding pocket. Both side chains pointed in opposite directions. CeuE showed Lys62
on the heme binding pocket. Lys62 was located on the opposite side of His229, closer to Met78.

14

Lys62 side chain points towards the center of the pocket. BtuF showed Lys62 and Lys237 on the
heme binding pocket. Arg206 and Arg226 are on the heme binding pocket also. Arg206 seemed
to be in a better position to bind than Arg226. FeuA showed Arg206 and Lys62 in the heme
binding pocket. Arg206 and Lys62 were located in opposite sides of the pocket. Both amino
acids pointed in the same direction. However, Lys62 was closer to Met78 and Arg206 was closer
to His229. Lys and Arg seemed to be the only positively charged amino acids on the heme
binding pocket.
1.5.2 Expression and Purification of H229A
The expression of H229A was confirmed by a band at 37 kDa shown in the Western Blot in
Figure 5. The isolation of H229A from other proteins was achieved by FPLC (Figure 6) using a
nickel column affinity described by the method above. The SDS-PAGE in Figure 6 shows a
single band at 37 kD. The spectrum for H229A (Figure 7) shows that the Soret band is
approximately 5-10% the band at 280 nm.
1.6. Conclusion
Expression and purification of H229A was achieved as shown by the SDS-PAGE and Western
Blot. Figure 7 shows the UV-visible spectrum of H229A. The low Soret band indicates that
histidine (one of the axial ligands of SiaA) to alanine, results in substantial heme loss. The Soret
band is only around 10% of the protein band at 280 nm. These data are consistent with H229 as
an axial ligand for the heme.
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Figure 1. ATP binding cassette (ABC) transport system: SiaABC and schematic diagram of the
SiaA/Hts Gene Cluster.
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Figure 2. A model of the His and Met axial ligands of SiaA. Histidine and methionine bind
heme in SiaA from opposite sides.
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Figure 3. SiaA threaded into IsdE (2Q8Q.pdb) (Grigg et al., 2007a). The axial ligands are shown
in red (Met79) and blue (His229). This structure was visualized using Pymol (DeLano, 2009).
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Figure 4. SiaA homology modeling. The SiaA sequence was threaded into homologous
sequences with known crystal structures using the program LOOPP. Three models of SiaA were
obtained: BtuF (1N2Z_A) (Borths et al., 2002), CeuE (2CHU_A) (Muller et al., 2006), and FhuD
(1K7S_N) (Clarke et al., 2002). The structures were visualized using Rasmol.

19

Lanes

1

2

37 kD

Figure 5. Western Blot of SiaA. Lane 1: Protein ladder. Lane 2: H229A grown in E. coli. The
antibodies antiSiaA and antirabbit were used. The heavy band at 37 kD is H229A SiaA.
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Binding Buffer A:
50 mM phosphate,
250 mM NaCl,
pH 8.0

Elution Buffer B:
50 mM phosphate,
250 mM NaCl,
0.5 M imidazole,
pH 8.0

Figure 6. FPLC purification of the mutant of SiaA H229A. A nickel column affinity was used.
Buffers A and B were the binding and elution buffers, respectively; the trace was visualized at
280 nm. Fractions 17-21 were collected and centrifuged. A light band was seen for the combined
fractions on SDS PAGE.
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Figure 7. UV-visible spectrum of the H229A mutant after purification in 10 mM Tris-HCl
buffer. The small size of the band at 420 nm with respect to the protein band at 288 nm indicates
that heme is lost easily from this mutant.
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CHAPTER 2. THE NEAT DOMAIN

2.1 S. pyogenes NEAT domains.
Another protein related to the ABC transporters discussed in Chapter 1.2 is Shr with a
molecular weight of 139 kD (Aranda et al., 2007). UV-visible spectroscopy shows that Shr can
bind heme as demonstrated by a peak at 410 nm. Shr contains two NEAT domains (Aranda et
al., 2007; Zhu et al., 2008a; Zhu et al., 2008a). Shr binds and transfers beme to apo Shp.
However, this heme binding protein does not transfers heme efficiently to apo SiaA.
The goal of this work was to prepare the second of these NEAT domains, designated
herein as NEAT2 for characterization. The text below summarizes the other known heme
binding NEAT domains.
2.2 Discovery of the NEAT domain.
The “NEAr Transporter” (NEAT) domain, a conserved region of approximately 125
amino acids, was discovered by sequencing genomes of pathogenic bacteria related to iron
transport (Andrade et al., 2002). The composition of the NEAT domain is mostly β strands.
Approximately, 80% of the residues are conserved in the β strands. NEAT domains have an
amino-terminal signal sequence and a carboxy-terminal transmembrane region.
A single gene can have one or more NEAT domains. For example, S. aureus has two
NEAT domains in S_aur2, one in S_aur4, and one in S_aur3. The total number of NEAT
domains varies in different species. For example, S. pyogenes has two NEAT domains, whereas
B. halodurans has six NEAT domains. The loops between the beta strands vary in the number of
residues in different NEAT domains. For instance, between β 4 and β 5 the loop goes from 1
residue in L mon2 to 19 residues in L inn1 (Andrade et al., 2002).
2.3 Staphylococcus aureus NEAT domains
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Staphylococcus aureus is a Gram positive pathogenic bacterium that contains a system of
iron-regulated surface determinant (Isd) proteins which are involved in the acquisition of heme
and iron (Grigg et al., 2007b). The system of Isd proteins is similar to the ABC transport system
of S. pyogenes.
Staphylococcal strains that do not contain proper Isd systems were found to have fewer
infections in mice than wild type strains (Pilpa et al., 2009). This lead to the assumption that Isd
systems form part of the virulence system since the infections in mice were fewer when the Isd
systems were not working correctly.
The Isd heme pathway acquisition involves nine proteins (Pilpa et al., 2009). Four of
them are receptors (IsdA, IsdB, IsdC, and IsdH) which bind heme by NEAT domains. Not all the
NEAT domains in S. aureus bind heme (Cavallaro et al., 2008). For example, S. aureus str
MRSA2525 has three proteins that contain one or more NEAT domains, but only one of these
proteins can bind heme (Cavallaro et al., 2008).
IsdA, IsdB, and IsdH are attached by Sortease A and IsdC by Sortease C to the cell wall
(Clarke & Foster, 2008). IsdB and IsdH bind methemoglobin (MetHb) and IsdA binds heme and
other ligands (Pilpa et al., 2009). After heme is bound to these proteins, heme is transferred to
IsdC (Muryoi et al., 2008). IsdC transports heme to the IsdDEF system which delivers heme into
the cytoplasm (Pilpa et al., 2009). The last step is thought to involve IsdG or IsdI, which cleaves
the tetrapyrrole ring, releasing iron (Pilpa et al., 2009).
2.3.1 IsdA NEAT domain
IsdA contains one NEAT domain that binds heme. UV-visible spectroscopy shows that
IsdA NEAT domains can bind heme as demonstrated by a peak at 407 nm (Grigg et al., 2007b).
The axial ligand for IsdA is Tyr166. The crystal structure of apo and holo IsdA NEAT domain
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structures do not show major differences (Grigg et al., 2007b). Mass spectrometry indicates that
IsdA apo NEAT has a series of peaks centered around a charge distribution of +8. IsdA holo
NEAT has a charge distribution peak of + 8. The presence of hemin does not change the charge
distribution; this led to the assumption that there is not major conformational change in the
protein when it binds heme (Grigg et al., 2007b).
2.3.2 IsdB NEAT domain
IsdB is a surface protein anchored to the cell wall (Pishchany et al., 2009). IsdB contains
two NEAT domains; IsdBN1 with 130 and IsdBN2 with 126 amino acids (Pilpa et al., 2009).
IsdBN1 has more similarities with IsdHN1 and IsdHN2, whereas IsdBN2 has more similarities with
IsdHN3. Both IsdB NEAT domains act as receptors for heme. IsdB binds heme from hemoglobin
and not free heme (Torres et al., 2006). IsdB can obtain heme from hemoglobin and transport it
to IsdA (Muryoi et al., 2008; Zhu et al., 2008a; Pishchany et al., 2009).
2.3.3 IsdC NEAT domain
IsdC is a surface protein anchored to the cell wall. IsdC contains one NEAT domain that
binds heme. IsdC can obtain heme from both hemoglobin and from other sources (Pilpa et al.,
2009). The crystal structure of the heme-bound NEAT domain of IsdC (Figure 11) shows eight
β-sheets, one α-helix, and nine to ten loops. IsdC has a five coordinate heme center with Tyr132
as the axial ligand (Villareal et al., 2008). Pluym et al. have investigated the conformation of
IsdC using mass spectroscopy (Pluym et al., 2008). The apo form of the NEAT domain in IsdC
has two charge distribution peaks of +8 and +9. The holo form of the NEAT domain also has
charge distribution peaks of +8 and +9 (Pluym et al., 2008). The observation that the charge
distribution peaks remains the same in the apo and holo forms leads to the assumption that there
is no major conformational change in the protein when it binds heme (Pluym et al., 2008).
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Electron spray ionization mass spectrometry (ESI-MS) has also been used to probe heme
transfer. Experiments show that heme is transferred to the NEAT domain of apo IsdC from the
holo NEAT domains of IsdA, IsdB, and IsdHN3 (Muryoi et al., 2008). For example, when the
NEAT domain of apo IsdC was mixed with NEAT domain of holo IsdA, the spectrum showed
peaks for apo IsdC (14442 amu), apo IsdA (14626 amu), and holo IsdC (15059 amu). The
absence of the holo IsdA indicates heme transfer from holo IsdA to apo IsdC.
2.3.4 IsdH NEAT domain
IsdH contains three NEAT domains. IsdHN1, IsdHN2, and IsdHN3 are composed of 144,
143, 126 amino acids, respectively (Muryoi et al., 2008). IsdHN1, IsdHN2 and IsdBN1 have
conserved amino acids and share a 46-65% identity (Pilpa et al., 2009). IsdHN1 and IsdHN2 are
known to bind methemoglobin (MetHb) and haptoglobin (Hp); the third domain IsdHN3 was
found to bind heme from MetHb (Pilpa et al., 2009). As isolated from culture, only IsdHN3
showed a Soret band (412 nm) (Watanabe et al., 2008).
The crystal structure of IsdHN3 shows three α-helices and eight β-strands (Watanabe et
al., 2008). This protein has a five coordinate heme center with Tyr642 as the axial ligand of the
iron. Mutation of Tyr642 to alanine showed a shift in the Soret band. However, heme still
appeared to bind.
2.4 δ-Aminolevulinic Acid
δ-Aminolevulinic acid (ALA) is a heme precursor which is often used in expression of
proteins to promote the production of holo protein (Austin et al., 2004). The synthesis of ALA is
the first committed step in the synthesis of heme (Cavallaro et al., 2008; Heinemann et al., 2008).
Succinyl CoA and glycine condense to form ALA, releasing CoA and CO2. ALA is added to the
culture before the inducer. Several proteins have shown an increase in holo protein production
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when ALA is used during expression. Optimization experiments are carried out for each protein
in order to determine the amount of ALA that must be added during the expression. Often, iron is
added along with the ALA to ensure that there is sufficient free iron to synthesize heme (Austin
et al., 2004).
An example of a successful use of ALA is in the production of indoleamine 2,3dioxygenase (IDO), an enzyme involved in tryptophan metabolism (Austin et al., 2004). IDO
expression with addition of hemin yielded 1.4 mg of protein per 1 L broth. Austin and coworkers also expressed the protein using various concentrations of ALA and ALA along with
ammonium iron (III) citrate. The addition of iron did not increase the yield of protein. ALA was
added to give final concentrations ranging from 0.1 to 1 mM. The ALA concentration yielding
the greatest protein activity was 1 mM ALA (~20 µmol/h/mg of protein). However, they found
that 1 mM ALA was the upper limit that this bacterium could tolerate and therefore used 0.5 mM
ALA for expression, yielding ~ 14 µmol/h/mg (Austin et al., 2004). The optimized expression
gave 3.5 mg IDO per 1 L broth. A second example is hydroperoxide lyase P450 cytochrome
(Delcarte et al., 2003). The addition of iron did not increase the amount of protein. However, the
addition of 2.5 mM ALA doubled the amount of protein (Delcarte et al., 2003). In general, ALA
produces higher expression yields of cytochromes P450.
2.5 Experimental
Luria-Bertani Agar (LB, 500 mL) was made by mixing 5 g sodium chloride (NaCl) (Aldrich
Chemicals, Milwaukee, WI), 5 g of tryptone (Becton Dickinson, Sparks, MD), 2.5 g of BactoTM
yeast extract (Becton Dickinson), 10 g agar (Becton Dickinson), and 18 MΩ water (Barnstead
NANOpure Diamond purifier) (VWR, Batavia, IL) to a final volume of 500 mL. The pH was
adjusted to 7.04 with NaOH. The solution was autoclaved (Amsco remanufactured 3021 gravity
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sterilizer) on a liquid cycle for 15 min, cooled to room temperature. A total of 400 µl of
ampicillin (AMP) (100 mg/mL stock solution) [(made by diluting 1 g of AMP sodium salt
(Fisher Scientific, Fair Lawn NJ) to 10 mL sterile water] was added to the broth. The solution
was poured into 11 Petri dishes.
NEAT2 plate inoculation. Using aseptic techniques, Strep-tag Shr-ddNEAT2 [a gift from Dr.
Eichenbaum (Georgia State University)] was inoculated into two LB agar plates. These plates
were incubated overnight at -20 ºC.
LB medium preparation. A batch of LB medium was made by adding 15 g tryptone, 7.5 g
BactoTM yeast extract, 15 g NaCl, and 1500 mL water to a 2.8 L Erlenmeyer flask. The pH was
adjusted to 7.01 by addition of aqueous NaOH. The solution was autoclaved using the liquid
cycle for 15 min and cooled to room temperature. A total of 1.5 mL AMP stock solution was
added to the LB medium. LB medium (30 mL) was added to a 125 mL Erlenmeyer flask.
LB medium inoculation and growth of NEAT2. Under sterile conditions, Strep-tag ShrddNEAT2 was added with an inoculating loop to the LB medium (30 mL) solution in a 125 mL
Erlenmeyer flask. The solution was shaken overnight (~16 h) at 37 °C and 225 rpm. The
remaining LB solution (~1470 mL at room temperature) was mixed with the inoculated solution
at which the OD600 was about 0.07. The solution was shaken for 7.5 h at 30 °C and 225 rpm to a
final OD600 of 0.6. A total of 150 µL of anhydrotetracycline (AHT) (made by adding 2 mg/mL to
a final concentration of 200 ng/mL) was added to the LB broth. The LB broth was shaken
overnight (~16 h) at 27 ºC and 225 rpm. The culture broth was evenly distributed into 1 L sterile
plastic centrifuge bottles and centrifuged at 8000 x g for 5 min at 4 °C. The supernatant was
discarded and the cell pellet was stored in the -80 °C freezer.
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Addition of ALA and iron sulfate heptahydrate (FeSO4 · 7 H2O) to the LB medium. Under
sterile conditions, Strep-tag Shr-ddNEAT2 was added with an inoculating loop to the LB
medium (30 mL) solution in a 125 mL Erlenmeyer flask. The solution was shaken overnight
(~16 h) at 37 °C and 225 rpm. The remaining LB solution (~1470 mL at room temperature) was
mixed with the inoculated solution at which the OD600 was about 0.07. The solution was shaken
until an OD600 of 0.3. ALA (Acros Organics, New Jersey USA) was added to a final
concentration of 103 µM and FeSO4 · 7 H2O (Aldrich Chemical Company, Milwaukee, WI) was
added to a final concentration of 40 µM to the broth at a 0.4 OD600. The solution was shaken at
30 °C and 225 rpm to a final OD600 of 0.6. A total of 150 µL of 200 ng/mL AHT was added to
the LB broth. The LB broth was shaken overnight (~16 h) at 27 ºC and 225 rpm. The culture
broth was evenly distributed into 1 L sterile plastic centrifuge bottles and centrifuged at 8000 x g
for 5 min at 4 °C. The supernatant was discarded and the cell pellet was stored in the -80 °C
freezer.
Modified Lowry Protein Assay. A Modified Lowry Protein Assay kit (Pierce, Rockford, IL)
was used for this experiment. Diluted albumin (BSA) standards were prepared to construct a
standard curve. The specific volumes for the solutions used for the standards were listed in a
table in the manual of the kit. A total of 0.2 L of purified NEAT2 was added to an Eppendorf
tube. At 15 s intervals between each sample including the standards, 1 mL of Modified Lowry
Reagent (provided by the kit) was added. The samples were incubated for 10 min at room
temperature. A total of 100 µL of 1X Folin-Ciocalteu Reagent [made by diluting 2X (2N)
reagent (provided by the kit) with water in a 1:1 ratio] was added to each sample including the
standards. The samples were incubated for 30 min at room temperature. The absorbance of all
the samples was measured via UV-visible spectroscopy at 750 nm. The blank standard was used
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to correct the absorbance of the rest of the samples. The BSA standards were used to construct a
standard curve by plotting absorbance vs. concentration (µg/mL). The concentration of the
samples at 750 nm was calculated from the standard curve. The total amount of holo NEAT2
was calculated multiplying the concentration of the sample and the total amount of the sample
(200 µL). The amount obtained from this assay was compared to the sample obtained in UVvisible spectroscopy for some samples.
FPLC (Fast Protein Liquid Chromatography). Buffer A 10X (150 mL) was prepared by
adding 13.1 g NaCl, 18.1 g Tris-Cl and 150 mL autoclaved water in an Erlenmeyer flask. The pH
was adjusted to 8.09 with HCl. The solution was filtered using a how Nalgene disposable bottle
top filter 150 mL 0.45 μm pore size. Buffer A (500 mL) was prepared with 50 mL Buffer A 10X
and 450 mL water. Buffer B (100 mL) was prepared by adding 0.06 g of desthiobiotin (SigmaAldrich, St. Louis, MO) and 100 mL of Buffer A. Buffer R (200 mL) was prepared by adding
0.04 g 2-(4-Hydroxyphenylazo) benzoic acid (HABA) (Sigma-Aldrich) and 200 mL of Buffer A.
The superloop was washed with water and pump A and B were washed with buffer A and
B, respectively. The Strep Tactin Superflow high capacity column (Strep-tag) (IBA, St. Louis,
MO) with a 5 mL bed volume was washed with 50 mL buffer A. The column was regenerated
with buffer R. The protein in solution was inserted to the system with a syringe. A step gradient
method was used with 5 column volumes.
UV-visible spectroscopy. A Cary 50 Bio UV-visible spectrophotometer was used for all the
absorbance determinations. To each 100 µL of protein, 300 µL of 20 mM Tris-Cl 10% glycerol
buffer (recipe) were added in a 6Q cuvette. The base line was done with the blank sample that
contained the buffer 20 mM Tris-Cl 10% glycerol. The range used for the spectrum was 800 –
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250 nm. To calculate the amount of holo NEAT2 in the sample the absorbance at the Soret band
was measured and the molar absorptivity used was 1.0 x 105 M-1cm-1.
2.6 Results and Discussion
2.6.1 Optimization of NEAT2
The goal of this work was to determine conditions that would yield substantial amounts
of holoprotein for spectroscopic studies. Holoprotein would also be needed to pursue x-ray
studies, as it is significantly easier to solve the structure when the crystal has only holoprotein,
rather than a mixture of holo- and apo-protein.
As outlined in the Materials and Methods section, several variables were changed in
order to determine which change will yield greater amounts of protein, as well as the highest
amount of holoprotein. Ten different experiments were run, and the amount of holoprotein (in
mg) calculated for each one.
Experiment I involved the standard conditions in use in the laboratory when this work
began. Figure 12 shows the cultures both before and after French press. It can be seen that the
majority of the protein is the desired NEAT2 (21 kD) (lane 2) and that very little is released upon
French pressing (lane 3). This presumably indicates that most of the protein is in inclusion
bodies. The purity of the protein is indicated both by the SDS-PAGE (Figure 12) as well as the
FPLC purification of the experiment (Figure 13). However, an SDS-PAGE run after FPLC
purification indicates that the protein shows an additional band that is of slightly lower molecular
weight (lane 2 of Figure 14). This may be due to proteolytic cleavage of the protein.
The spectrum of the protein from Experiment I (Figure 15) indicates that it is
approximately 52% holo protein (calculated from the 404 to 280 ratio of 1.30 and assuming a
fully holo ratio of 2.5). The shoulder at 422 nm is very probably due to the reduced form of the
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protein, which has been shown to absorb 429 nm (Figure 16). To see what would happen with
more available oxygen, growth was performed with half the amount of media (Experiment II).
Using the same shaking flask, this results in more surface area, and hence the option for more
oxygen to diffuse into the culture. Figure 12 compares the cultures from Experiment I and II both
before and after French press. It can be seen that reducing the volume of culture (increasing the
available oxygen) reduces the amount of NEAT2. The two experiments result in protein of
comparable purity as seen the SDS-PAGE (Figure 12 and in comparing the FPLC traces (Figures
13 and 17). The spectrum of the protein (Figure 18) indicates that is it approximately 26% holo
protein (calculated from the 404 to 280 ratio of 0.64).
The next experiment (Experiment III) involved growth at higher temperatures to see if
this would result in more protein. Specifically, the pre-culture, growth and after-inducer
temperatures were 34, 34, and 31 °C in comparison with the 30, 30 and 27 °C of Experiment I.
The SDS-PAGE before and after French press (lanes 2 and 3, respectively, of Figure 19) shows
that again, the protein is difficult to extract from the cells although there seems to be some more
protein in the supernatant of Experiment III in comparison to Experiment I. The protein appears
somewhat less pure in the SDS-PAGE (Figure 19) and also shows a leading small band in the
FPLC (Figure 20). The amount of holo protein calculated from the UV/vis spectrum (Figure 21)
was 0.39 g/L. The smaller amount of protein in comparison with Experiment I, and the
indications that it may not have been as pure, show that increasing the temperature was not a
successful route to high yields of holoprotein. Figure 14 shows the SDS-PAGE of NEAT2 from
Experiment II after FPLC purification. It can be seen that there are two heavier bands in the gel,
one at about 40 kD and the other at about 60 kD. This is also in line with the observation that the
protein may not be as pure as that isolated in Experiment I. However, there is another possibility.
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In a native gel, NEAT2 can be seen to form oligomers (Figure 22, data courtesy of Y. Zhuo). It is
possible that these heavier bands on the SDS-PAGE represent oligomers of NEAT2. If they do,
then the protein undergoes exceptionally tight self-association.
Experiment IV involved a high temperature for the pre-culture period (37 as opposed to
30 °C) and a slightly lower temperature after induction (25 as opposed to 27 °C). The SDSPAGE (Figure 23, lane 2) shows a large amount of pure protein of the desired molecular weight.
The FPLC (Figure 24) also indicates that the protein is pure. A MALDI mass spectrum was
performed of this protein (Figure 25). The observed mass (21758.2) is within 0.2% of the
predicted mass (21706.2), assuming cleavage between the Q and A in the sequence AQAAS.
The cleavage is performed by cellular proteases, and the exactly cleavage site is not known a
priori, but this mass spectrum is consistent with the desired protein. The UV/visible spectrum
indicated significant amount of the ferrous protein, as seen in the band at 429 nm (Figure 26).
Experiment V involved a high temperature for the pre-culture period (37 as opposed to 30
°C) but lower temperatures for growth (25 as opposed to 30 °C) and a slightly lower temperature
after induction (25 as opposed to 27 °C). The SDS-PAGE (Figure 23, lane 1) shows a significant
band for the desired protein but also, as seen in Experiment III, a band at approximately 60 kD.
Experiment V shows no band at approximately 40 kD, however. The FPLC (Figure 27) also
indicates that the protein is pure. The UV/visible spectrum (Figure 28) indicated only a small
amount of the ferrous protein, as seen in the shoulder at approximately 429 nm. The percent
holoprotein, calculated from the 407 to 280 ratio of 2.28, was 91% Although the overall amount
of protein was low (only 0.13 mg/L) this protocol gave the highest amount of holoprotein of
Experiments I – V.

33

A second series of experiments (A – C) involved differences in the time after addition of
the inducer AHT (in comparison with the 16 h of Experiment I). These experiments were run as
in Experiment IV, but on a 1.0 L scale, and with an after inducer temperature of 27 °C. In
Experiment A, only one hour was allowed between induction and centrifugation. Under these
conditions, no NEAT2 was observed (data not shown).
In Experiment B, 16 h were allowed between induction and centrifugation. This protocol
is the almost the same as Experiment IV, differing only in the amount of broth (1.0 vs. 1.5 L) and
after inducer temperature (27 vs. 25 °C). The FPLC of this protein indicated that it is pure
(Figure 29; there was no SDS PAGE for this experiment). The UV/visible spectrum (Figure 30)
indicated significant amounts of the reduced form of the protein. Experiment B produced about
0.21 mg/L of holoprotein. It should be noted that Experiment B gave 0.21 mg/L of holo NEAT2
whereas the very similar Experiment IV gave 1.07 mg/L of holoprotein. The significant
differences in protein isolated, even under very similar conditions, may indicate the difficulty of
solubilizing the protein into the supernatant.
Experiment C was the same as Experiment B, but with 14 h allowed between induction
and centrifugation. The FPLC of this protein indicated that it was pure (Figure 31; there was no
SDS PAGE for this experiment). The UV/visible spectrum (Figure 32) showed almost entirely
Fe(II) protein. Experiment C gave 0.79 mg/L of protein, much closer to Experiment IV than to
Experiment B. This again may indicate the difficulty of solubilizing the protein into the
supernatant.
A final set of experiments involved the addition of δ-aminolevulinic acid. As described
above this is a precursor to heme; the addition of ALA, with or without iron, can produce
significant additional amounts of holoprotein in certain systems. Experiment ALA involved the
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growth of the bacteria in the presence of 103 µM ALA without added iron. The protocol
followed Experiment B with the exception that it was run in 1.5 rather than in 1.0 L broth. Figure
33 lane 4 shows the NEAT2 after FPLC purification. It appears very pure. The FPLC (Figure 34)
is consistent with this. The UV/visible spectra (Figures 35 and 36) show significant amounts of
both oxidized and reduced protein. This experiment produced 0.87 mg/L holoprotein, which was
less than both Experiment I and Experiment IV. Thus, for this system, the addition of ALA alone
does not result in significant additional amounts of holoprotein.
The final experiment (Experiment ALA + iron) was the same as Experiment ALA, but
with the addition of 40 µM ferrous sulfate. Figure 33 lane 7 shows that the NEAT2 after FPLC
purification is pure. The FPLC (Figure 37) appears consistent with this. The UV/visible spectrum
(Figure 38) is very similar to that of Experiment ALA. This experiment produced 0.67 mg/L
holoprotein, similar to that of Experiment ALA. Even the addition of ALA and iron does not
result in significant additional amounts of holoprotein.
2.6.2 Expression and Purification of NEAT2
All the SDS-PAGE for each experiment showed a band at 21 kD which is correspondent
to the molecular weight of NEAT2. The SDS-PAGE shows a dark band at 21kDa before French
press. After French press, a much lighter band appears at 21 kD. This same pattern happens for
Exp I, II, and III. We believe that inclusion bodies are being formed during French press.
The single peak seen in the FPLC after addition of the eluting buffer shows the purification of
NEAT2. SDS-PAGE was run for the peaks in order to determine the purity. The results indicate
that the peak contains NEAT2 and does not show any other band at other weights. Therefore, it
can be concluded that NEAT2 was purified.
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To each batch that was grown, a UV-visible spectroscopy spectrum was taken to
determine the amount of holo protein obtained. The spectra showed Soret bands ranging from
400-410 nm. This is the region where heme proteins appear. The UV-visible spectra also showed
protein bands at 280 nm.
2.6.3 Calculation of Holo NEAT2 Protein Amount and Total Protein Using UV-visibleible
Spectroscopy and the Lowry Assay
The amount of total protein in Experiments II and III was calculated using the Lowry
Assay; the standard curve is shown in Figure 39. The amounts of NEAT2 were 0.74 and 0.47
mg/L, respectively. Using the program ProtParam tool (Gasteiger et al., 2005), the extinction
coefficient for NEAT2 was calculated from the sequence to be 24,410 M-1cm-1 at 280 nm. The
280 nm bands of Experiments II and III had absorbances of 0.056 and 0.135, respectively. Given
this extinction coefficient, and a molecular weight of 21706 kD, we calculate from the spectra
that the amounts of proteins are 0.89 and 2.1 mg/L for Experiments II and III, respectively.
Although these two ways of calculating the concentrations of total protein are of the same order
of magnitude, there are still significant differences. We believe that the differences in the total
protein calculated in these two ways arise from two issues. First, the actual extinction coefficient
at 280 nm will be higher than that calculated from the sequence due to a contribution from the
heme. Second, the spectra were probably too dilute for accurate calculations of this type
(especially for Experiment II, which does not have a clearly resolved 280 band).
UV-visible spectrometry was used to calculate the amount of holo NEAT2 protein in
each experiment. These calculations are inexact, because the extinction coefficient of pure
NEAT2 is not yet known and because in each case the isolated protein is a mixture of Fe(II) and
Fe(III). However, using a Soret to 280 nm ratio of 2.5, we can get an approximate idea of how
much holoprotein is in each experiment. These values are given in Tables I – III.
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2.6.4 Homology modeling.
To obtain a visual picture of NEAT2, the sequence of this protein from S. pyogenes was
threaded into its closest homology for which an X-ray structure is known IsdA from S. aureus,
using PyMol. Figure 40 shows the model. A tyrosine appears in an appropriate position to be the
axial ligand. However, reduction potential studies (D. Block and K.R. Rodgers, North Dakota
State University, unpublished) are not consistent with this conclusion. Additional spectroscopic
and structural work will be necessary to understand this system. It is to be noted that some heme
proteins have more than one axial ligand set depending on the circumstances.
2.6.5 Conclusions.
The focus of this work was to find conditions that optimized the production of holo
NEAT2 for spectroscopic studies. We observed that significant amounts of protein were not
found in the supernatant, and hence presumably are found in inclusion bodies. This difficultly of
solubilizing the protein made accurate comparison of different protocols challenging. Increasing
the amount of oxygen available to the bacteria seemed to inhibit protein production; the
optimization experiment yielding the least amount of protein was Experiment II. The addition of
ALA alone or ALA with iron can (but does not always) increase the amount of holoprotein in
heme protein growth experiments. For NEAT2, neither ALA nor ALA plus iron increased the
amount of holoprotein produced.
The time to induction may be more important. The original time for induction was
approximately 16 h. When this amount of time was reduced to 14 h, the amount of holoNEAT2
increased significantly. The amount of holo protein increased from ~ 0.2 mg/L to ~ 0.8 mg/L.
This seems a large change for a small difference in induction time, but indicates that induction
time may be a significant variable in holoprotein production.
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Probably the most significant variable is temperature. The optimization experiment that
yielded the greatest amount of protein was Experiment IV, in which the temperature after the
induction with AHT was decreased. Changing the temperature after induction to 25 °C produced
a higher amount of holoNEAT2 than at 31 °C or 20 °C. These results show that temperature is
one of the most important factors when it comes to the production of holoNEAT2.
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Table 1. The yield of NEAT2 as a function of expression variables. Each experiment followed
the general procedure outlined under the LB medium preparation, LB medium inoculation, and
growth of NEAT2 as discussed in the Materials and Methods section.

Variables
Tryptone (g)
Yeast extract
(g)
NaCl (g)
Water (L)
Lysis buffer
(mL)
Protease
inhibitor
tablets
Pre-culture
temperature
(ºC)
Growth
temperature
(ºC)
After inducer
temperature
(ºC)
Amount of
holoNEAT2
(mg)
using UVvisible
spectroscopy
Amount of
total protein
using Lowry
Assay (mg)
Percent
holoNEAT2
Amount of
holoNEAT2
(mg/L)

Experiment Experiment
I
II
7.5
3.8

Experiment
III
15

Experiment
IV
15

Experiment
V
15

3.8

1.9

7.5

7.5

7.5

7.5
0.75

3.8
0.38

15
1.5

15
1.5

15
1.5

20

10

40

40

40

2

1

4

4

4

30

30

34

37

37

30

30

34

30

25

27

27

31

25

20

1.5

0.06

0.58

1.6

0.2

Exp not
performed

0.28

0.71

Exp not
performed

Exp not
performed

52

26

49

25

91

2.0

0.16

0.39

1.07

0.13
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Table 2. The yields of NEAT2 as a function of time after the addition of inducer. Each
experiment was done in 1 L broth, with temperatures of 37 (pre-culture), 30 (growth), 27 (after
inducer) ºC.

Variables
Time after addition of
AHT (h)
Amount of
holoNEAT2 (mg)
Percent holoNEAT2
Amount of
holoNEAT2 (mg/L)

Experiment
A

Experiment
B

Experiment
C

1

16

14

0.210

0.789

28

35

.210

0.789

No protein
observed
-

Table 3. The yields of NEAT2 with ALA and iron. Each experiment was done in 1.5 L broth,
with temperatures 37 (pre-culture), 30 (growth), 27 (after inducer) ºC, and 16 h induction time.

Variables
[ALA] µM
[FeSO4.7H2O] µM
Amount of holoNEAT2
(mg)
Percent holoNEAT2
Amount of holoNEAT2
(mg/L)

Experiment
ALA
103
0

Experiment
ALA + Iron
103
40

1.3

1.0

48

41

0.87

0.67

40

MKKTAIAIAVALAGFATVAQAASWSHPQFEKSGGGGGLVPRGSRDRGPEFLNQKQ
LRDGIYYLNASMLKTDLASESMSNKAINHRVTLVVKKGVSYLEVEFRGIKVGKML
GYLGELNYFVDGYQRDLAGKPVGRTKKAEVVSYFTDVTGLPLADRYGKNYPKVL
RMKLIEQAKKDGLVPLQVFVPIMDAISKGSGLQTVFMRLDWASLTTEKAKVV
OmpA leader – Strep tag – linker – thrombin cleavage site – N2

Figure 8. Shr-NEAT2 construct. This sequence is composed of the OmpA leader (outer
membrane protein A, red), a Strep tag sequence used for purification (green), a linker (black),
and a potential thrombin cleavage site (blue, thrombin cleavage would occur between arginine
and glycine), and the sequence of NEAT2.

41

Figure 9. Representation of NEAT domains found in Shr (S. pyogenes, two NEAT domains),
and the S. aureus proteins IsdH (three NEAT domains), IsdB (two NEAT domains), IsdC (one
NEAT domain), and IsdA (one NEAT domain). These diagrams were generated using Pfam
(Finn et al., 2008). The green circles are domains of unknown function (DUF); the yellow
regions are leucine rich repeats; the light blue square in the C terminal region is a Gram positive
anchor; and the purple square in the N terminal region represents the YSIRK-type signal peptide
(Finn et al., 2008).
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Figure 10. IsdA NEAT holo crystal structure (2ITF.pdb). Helices are shown in light blue, sheets
are magenta, and loops are light pink. The axial ligand Tyr 166 is shown in green binding to
heme which is red. Figure created in PyMOL from the data in (Grigg et al., 2007b).
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Figure 11. IsdC NEAT holo crystal structure (2O6P.pdb), a closer look to the heme binding
pocket. Helices are indicated with ribbons and colored light blue, beta sheets are indicated with
arrows and colored magenta, and loops are light pink. The axial ligand, Tyr 132, is shown in
green binding to heme which is red. Figure created by PyMOL from the data in (Sharp et al.,
2007).

44

Lanes

1

2

3

4

5

75 kD
50 kD
37 kD

25 kD
20 kD

Figure 12. SDS-PAGE of NEAT2 grown in different amounts of broth. Lane 1: protein ladder.
Lanes 2 and 3: NEAT2 grown in Experiment II [0.38 L culture (pre-culture, growth, and afterinducer temperatures of 30, 30, and 27 ºC, respectively)] before French press (lane 2) and after
French press (lane 3). Lanes 4 and 5: NEAT2 grown in Experiment I [0.75 L culture (preculture, growth, and after-inducer temperatures of 30, 30, and 27 ºC, respectively)] before French
press (lane 4) and after French press (lane 5).
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Figure 13. FPLC purification of NEAT2 grown in Experiment I by the stepwise method on a
Strep Tactin Superflow high capacity column (IBA, St. Louis, MO, 5 mL). Buffers A and B were
the binding and elution buffers, respectively. Fractions 15-19 were collected for centrifugation.
Data taken at 280 nm.

46

Lanes

1

2

3

75 kD

50 kD

37 kD

25 kD
20 kD

Figure 14. SDS-PAGE of Experiment I and Experiment III. Lane 1: protein ladder. Lane 2:
NEAT2 grown in Experiment I after purification (0.75 L culture, pre-culture, growth, and afterinducer temperatures of 30, 30, and 27 ºC, respectively). Lane 3: NEAT2 grown in Experiment
III after purification (1.5 L culture, (pre-culture, growth, and after-inducer temperatures of 34,
34, and 31 ºC, respectively).
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550
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Figure 15. UV-visible spectroscopy of NEAT2 grown in Experiment I after purification (20
mM Tris, pH 8.0). The 404 to 280 ratio is 1.30. The shoulder at 422 nm is presumed to be the
Fe(II) form of the protein. Maxima are also observed at 540, 560 and 652 nm.
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Figure 16. UV-visible spectra of oxidized (black) and reduced (red) NEAT2 in 50 mM Tris HCl,
pH 8.0, 100 mM NaCl. Data taken by Darci Block in the laboratory of Dr. Kenton Rodgers.
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Figure 17. FPLC purification of NEAT2 grown in Experiment II by stepwise method on a
Strep Tactin Superflow high capacity column (IBA, St. Loius, MO, 5 mL). Buffers A and B were
the binding and elution buffers, respectively. Fractions 13-16 were collected for centrifugation.
Data taken at 280 nm.
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Figure 18. UV-visible spectrum of NEAT2 grown in Experiment II after purification (20 mM
Tris, pH 8.0). The 404 to 280 ratio is 0.64.
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Figure 19. SDS-PAGE of NEAT2 grown with different temperatures, Experiments III and IV.
Lane 1: protein ladder. Lanes 2 and 3: NEAT2 grown in Experiment III (pre-culture, growth,
and after-inducer temperatures of 34, 34, and 31 ºC, respectively) before (lane 2) and after (lane
3) French Press. Lanes 4, 5, 6 and 7: NEAT2 grown in Experiment IV (pre-culture, growth, and
after-inducer temperatures of 37, 30, and 25 ºC, respectively) before French Press (lane 4), after
French Press (lane 5), Pellet 1 (lane 6), and Pellet 2 (lane 7). Lanes 8, 9, 10 and 11: NEAT2
grown in Experiment V (pre-culture, growth, and after-inducer temperatures of 37, 25, and 20
ºC, respectively) before French Press (lane 8), after French Press (lane 9), Pellet 1 (lane 11) and
Pellet 2 (lane 12).
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Figure 20. FPLC purification of NEAT2 grown in Experiment III by stepwise method on a
Strep Tactin Superflow high capacity column (IBA, St. Loius, MO, 5 mL). Buffers A and B were
the binding and elution buffers, respectively. Fractions 17-24 were collected for centrifugation.
Data taken at 280 nm.
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Figure 21. UV-visible spectrum of NEAT2 grown in Experiment III after purification in (20
mM Tris, pH 8.0). The 405 to 280 ratio is 1.23. The shoulder at 425 nm is presumed to be the
Fe(II) form of the protein. Maxima are also observed at 527, 556 and 652 nm.

55

Lane

1

2

250 kD
150 kD
100 kD
75 kD

50 kD

37 kD

25 kD

Figure 22. ZhuoNEAT2_ 6. ZYII40. Native PAGE. Lane 1: protein ladder. Lane 2: is NEAT2
(Delgado’s sample Experiment C). Data taken by Y. Zhuo.
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Figure 23. SDS-PAGE of NEAT2 grown with different temperatures, Experiments IV and V.
Lane 1: NEAT2 grown in Experiment V (1.5 L culture, pre-culture, growth, and after-inducer
temperatures of 37, 25, and 20 ºC, respectively). Lane 2: NEAT2 grown in Experiment IV (1.5
L culture, pre-culture, growth, and after-inducer temperatures of 37, 30, and 25 ºC, respectively).
Lane 3: protein ladder.
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Figure 24. FPLC purification of NEAT2 grown in Experiment IV by stepwise method on a
Strep Tactin Superflow high capacity column (IBA, St. Loius, MO, 5 mL). Buffers A and B were
the binding and elution buffers, respectively. Fractions 20-32 were collected for centrifugation.
Data taken at 280 nm.
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Figure 25. Mass spectrum of Experiment IV. The technique used was MALDI in the positive
mode. The major peak was observed at 21758.2. The predicted mass for cleavage between Q and
A in the sequence AQAAS is 21706.18. The experimental mass is within 0.2% of the predicted
mass.
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Figure 26. UV-visible spectrum of NEAT2 grown in Experiment IV after purification (20 mM
Tris, pH 8.0). The 413 to 280 ratio is 0.613. The shoulder at 413 nm is presumed to be the Fe(III)
form of the protein. The shoulder at 429 is presumed to be the Fe(II) of the protein. Maxima are
also observed at 538 and 567 nm.
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Figure 28. UV-visible spectrum of NEAT2 grown in Experiment V after purification in (20
mM Tris, pH 8.0). The 407 to 280 ratio is 2.28. The shoulder at 429 nm is presumed to be the
Fe(II) form of the protein.
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Figure 29. FPLC purification of NEAT2 grown in Experiment B by stepwise method on a Strep
Tactin Superflow high capacity column (IBA, St. Loius, MO, 5 mL). Buffers A and B were the
binding and elution buffers, respectively. Fractions 10-14 were collected for centrifugation. Data
taken at 280 nm.
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Figure 30. UV-visible spectrum of NEAT2 grown in Experiment B after purification (20 mM
Tris, pH 8.0). The 404 to 280 ratio is 0.71. The shoulder at 426 nm is presumed to be the Fe (II)
form of the protein. Maxima are also observed at 525, 555 and 651 nm.
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.

Figure 31. FPLC purification of NEAT2 grown in Experiment C by stepwise method on a Strep
Tactin Superflow high capacity column (IBA, St. Loius, MO, 5 mL). Buffers A and B were the
binding and elution buffers, respectively. Fractions 23-25 were collected for centrifugation. Data
taken at 280 nm.
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Figure 32. UV-visible spectrum of NEAT2 grown in Experiment C after purification (20 mM
Tris, pH 8.0). The 427 to 273 ratio is 0.87. The shoulder at 406 nm is presumed to be the Fe (III)
form of the protein. Maxima are also observed at 524 and 557 nm. Note that this protein was
isolated largely in the reduced form.
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Figure 33. SDS-PAGE of NEAT2 grown with different ALA and ALA plus Iron
concentrations. Lane 1: protein ladder. Lane 2 and 3: NEAT2 grown in Experiment ALA before
(lane 2) and after (lane 3) French press. Lane 4: NEAT2 grown in Experiment ALA after
purification. Lane 5 and 6: NEAT2 grown in Experiment ALA plus Iron before (lane 5) and after
(lane 6) French press. Lane 7: NEAT2 grown n Experiment ALA plus Iron after purification.
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Figure 34. FPLC purification of NEAT2 grown in Experiment ALA by stepwise method on a
Strep Tactin Superflow high capacity column (IBA, St. Loius, MO, 5 mL). Buffers A and B were
the binding and elution buffers, respectively. Fractions 21-26 were collected for centrifugation.
Data taken at 280 nm.
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Figure 35. UV-visible spectrum of NEAT2 grown in Experiment ALA after purification (20
mM Tris, pH 8.0) fractions 21-23. The 428 to 280 ratio is 1.20. The shoulder at 419 nm is
presumed to be the Fe(III) form of the protein. Maxima are also observed at 538, 564 and 656
nm.
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Figure 36. UV-visible spectrum of NEAT2 grown in Experiment ALA Fractions 24-26 after
purification (20 mM Tris, pH 8.0). The 429 to 276 ratio is 0.626. The shoulder at 414 nm is
presumed to be the Fe(III) form of the protein. Maxima are also observed at 538 and 565 nm.
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Figure 37. FPLC purification of NEAT2 grown in Experiment ALA plus Iron by stepwise
method on a Strep Tactin Superflow high capacity column (IBA, St. Loius, MO, 5 mL). Buffers
A and B were the binding and elution buffers, respectively. Fractions 21-25 were collected for
centrifugation. Data taken at 280 nm.
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Figure 38. UV-visible spectrum of NEAT2 grown in Experiment ALA and iron after
purification (20 mM Tris, pH 8.0). The 429 to 277 ratio is 1.03. The shoulder at 419 nm is
presumed to be the Fe(III) form of the protein. Maxima are also observed at 535, 564 and 655
nm.
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Figure 39. Lowry assay standard curve using a modified Lowry Protein Assay kit (Pierce,
Rockford, IL). Diluted albumin (BSA) standards were prepared to construct a standard curve.
Absorbance vs. concentration plot of known concentrations samples used to calculate unknown
concentrations.
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Figure 40. Shr-NEAT2 threaded into IsdA (2ITF.pdb). NEAT2 is green and IsdA is blue.
Tyrosine is the axial ligand binding to heme (red). Helixes are indicated with ribbons and beta
sheets are indicated with arrows. Figure created by PyMOL from the data in (Grigg et al.,
2007b).
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